EUCTR2019-002638-36-DK进行中（未招募）1 期
Glucagon Dose-response Relationship for Cardiovascular Activity A Randomized, participant-blinded, Crossover Study
Bispebjerg Hospital, University of Copenhagen0 个研究点目标入组 8 人开始时间: 2019年6月27日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 8
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Male
入选标准
- •Eligible participants are males 18 to 40 years of age determined to be
- •healthy by physical examination, medical history and routine laboratory
- •tests (blood and urine) - i.e. normal levels of sodium, potassium,
- •calcium, liver function, kidney function, hematological parameters,
- •albumin, HbA1c, lipid levels.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 8
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Routine laboratory tests outside normal ranges
- •Hypertension
- •Second and third degree atrioventricular conduction block
- •Resting Systolic blood pressure >140 or <100 mmHg
- •Resting heart rate < 45 beats per minute (bpm)
- •Sick sinus syndrome
- •Pheochromocytoma
- •Chronic obstructive pulmonary disease
- •Abnormal body mass index
- •Claudicatio intermittens
- •Raynaud syndrome
- •Latex allergy
- •Any contraindications to glucagon
- •Any other previous or existing metabolic, heart or lung disease
研究者
相似试验
招募中
不适用
Study of glucagon response and its association with glycemic control and variability after administration of ipragliflozin as an adjunctive to insulin treatment in patients with type 1 diabetes (Suglat-AID): a single-arm, multicenter, open-label,prospective exploratory trialtype 1 diabetesJPRN-UMIN000039635agasaki University Hospital24
进行中（未招募）
不适用
Testing Whether Glucagon Solutions Affect the Glucose Levels in the Fat Tissue of Diabetic Patients.EUCTR2014-002341-22-ATMedizinische Universität Graz; Universitätsklinik für InnereMedizin; Abteilung für Endokrinologie und Stoffwechsel
已完成
不适用
Evaluation of change in blood glucagon levels in response to orally glucose loading and food intakeDiabetes mellitusJPRN-UMIN000027852Gunma University70
已完成
不适用
Effect of the glucagon suppression ability in the sulfonylurea agents and other oral hypoglycemic agents.Type 2 diabetesJPRN-UMIN000007378Divison of Diabetes and Metabolism,Itabashi Hospital, Nihon University School of Medicine200
Unknown
4 期
Effect of Glucagon and Glucagon-like Peptide-1 Co-agonism on Cardiac Function and Metabolism in Overweight Participants With Type 2 DiabetesType 2 DiabetesObesityNCT04307797Cambridge University Hospitals NHS Foundation Trust16